捷順科技(002609.SZ):聯合體中標2689.99萬元宏立城智慧停車系統及設備採購項目
格隆匯 12 月 2日丨捷順科技(002609.SZ)公佈,近日,公司收到招標人貴州宜行智通科技有限公司(“宜行智通”)發出的《中標通知書》,經宜行智通決策機構評審,確認捷順科技及阿里雲計算有限公司(聯合體)為“宏立城智慧停車系統及設備採購項目”的中標單位,中標金額為人民幣2689.99萬元。
此次項目中標,捷順科技作為智慧停車整體解決方案提供方,向客户提供智能硬件、平台技術、移動應用等,構建智能化、線上化的停車應用,提升客户管理水平及效率。此次中標項目的順利實施交付,公司將會打造大型社區智慧停車整體解決方案樣板並進行推廣,同時會促進公司智慧停車業務在貴陽的發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.